Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05765175 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05765175 · ClinicalTrials.gov record · last posted 2026-04-22

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

Study acronym: RADIATE-VT
StatusRecruiting
PhaseNot applicable
Started2023-04-21
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 22, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
RADIATE-VT is a pivotal, multicenter, randomized trial comparing safety and efficacy between cardiac radioablation (CRA) using the Varian CRA System and repeat catheter ablation (CA), for patients with high-risk refractory ventricular tachycardia (VT) who have experienced VT recurrence after CA and are candidates for additional CA.

Amendment record 11 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 11 times since 2023-02-28; most recent amendment 2026-04-17. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2023-04-23
Status change Not Yet Recruiting→Recruitingv2
Trial Details
NCT Number NCT05765175
Lead Sponsor Varian, a Siemens Healthineers Company
Conditions Tachycardia, Ventricular
Enrollment 380 participants
Start Date 2023-04-21
Primary Completion 2026-05 (estimated)
Study Completion 2030-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-22